Drug name - Nucynta

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
USRE39593 COLLEGIUM PHARM INC 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effects
Aug, 2022

(2 months ago)

US7994364 COLLEGIUM PHARM INC Crystalline forms of (−)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
Jun, 2025

(2 years from now)

CN1077566C COLLEGIUM PHARM INC Having Pharmacological Effect Of 1-Phenyl - -3 - Dimethylamino-Propane Compounds
Jul, 2015

(7 years ago)

CN1125221A COLLEGIUM PHARM INC Having Pharmacological Effect Of 1-Phenyl - -3 - Dimethylamino-Propane Compounds
Jul, 2015

(7 years ago)

CN1997621A COLLEGIUM PHARM INC Crystalline Form Of (-)-(1R, 2R)-3-(3-Dimethylamino-1-Ethide-2-Methyl Propyl)-Phenol Hydrochloride
Jun, 2025

(2 years from now)

CN1997621B COLLEGIUM PHARM INC (-)-(1R, 2R) -3-(3-Dimethylamino - -1 - Ethyl -2 - Methyl Propyl) - Phenol Hydrochloride Of Crystalline Form
Jun, 2025

(2 years from now)

IN242353B COLLEGIUM PHARM INC Crystalline Forms Of (-) -(1R, 2R) -3-(3-Dime Thylamino-1- Ethyl -2 Methyl Propyl ) -Phenol Hydrochlo Ride
Jun, 2025

(2 years from now)

IN200603453P2 COLLEGIUM PHARM INC Crystalline Forms Of (−)-(1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methylpropyl)-Phenol Hydrochloride
Jun, 2025

(2 years from now)

EP693475B1 COLLEGIUM PHARM INC 1-Phenyl-3-Dimethylamino-Propane Derivatives Having Pharmacological Activity
Jul, 2020

(2 years ago)

EP693475A1 COLLEGIUM PHARM INC 1-Phenyl-3-Dimethylamino-Propane Derivatives Having Pharmacological Activity
Jul, 2020

(2 years ago)

EP1612203B1 COLLEGIUM PHARM INC Crystalline Forms Of (-)-(1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methylpropyl)-Phenol Hydrochloride
Jun, 2024

(1 year, 8 months from now)

EP1612203A1 COLLEGIUM PHARM INC Crystalline Forms Of (-)-(1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methylpropyl)-Phenol Hydrochloride
Jun, 2024

(1 year, 8 months from now)

EP1799633A2 COLLEGIUM PHARM INC Crystalline Forms Of (-)-(1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methylpropyl)-Phenol Hydrochloride For Use As Active Ingredient In Pharmaceutical Compositions
Jun, 2025

(2 years from now)

EP1799633B1 COLLEGIUM PHARM INC Crystalline Forms Of (-)-(1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methylpropyl)-Phenol Hydrochloride For Use As Active Ingredient In Pharmaceutical Compositions
Jun, 2025

(2 years from now)

More Information on Dosage
Strength Dosage Availability
EQ 20MG BASE/ML SOLUTION;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.